In the field of immunology and vaccine development, adjuvants are vital components that enhance the immune response elicited by vaccines. One such adjuvant, QS-21, a natural product extracted from the bark of the soap bark tree (Quillaja saponaria), is an attractive candidate for use in vaccines.
QS-21 is known for its ability to boost both humoral and cellular immune responses, enhances the immunogenicity of a wide range of antigens, making it a versatile adjuvant for different types of vaccines. It also has demonstrated a favorable safety profile in preclinical and clinical studies.
When selecting an adjuvant for a vaccine formulation, several factors need to be considered, including safety, efficacy, and compatibility with the antigen. QS-21 stands out as a promising adjuvant due to its potent immunostimulatory properties and favorable safety profile, makes it particularly attractive for vaccines targeting a broad range of infectious diseases and cancer.
Amaran is one of the few manufacturers capable of supplying GMP grade QS-21. Our existing client base comprises top 10 global pharmaceutical companies, leading research institutes and universities across Europe, North America, China, and Japan, as well as the top vaccine research organizations and manufacturers in China and India. We welcome your inquiries about the promising product.